Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer
Clinical trial NCT01483300 · UNKNOWN
Trial details
- NCT number
- NCT01483300
- Sponsor
- Harbin Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.